Literature DB >> 2868308

Outcome of 25 neuroblastomas revealed by mass screening in Japan.

T Sawada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2868308     DOI： 10.1016/s0140-6736(86)92335-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Screening for neuroblastoma.

Authors:  S N Huddart; J R Mann
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

2.  Neuroblastoma mass screening in infancy in Kyoto, Japan.

Authors:  T Sawada; H Kawakatsu; T Sugimoto; Y Horii; K Kuroda; H Hosoi; T Saida; T Hino; T Michihata
Journal:  Indian J Pediatr       Date:  1987 Nov-Dec       Impact factor: 1.967

Review 3.  Is neuroblastoma screening evaluation needed and feasible?

Authors:  J Estève; L Parker; P Roy; F Herrmann; S Duffy; D Frappaz; C Lasset; C Hill; H Sancho-Garnier; J Michaelis
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

4.  How frequent is spontaneous remission of neuroblastomas? Implications for screening.

Authors:  N L Carlsen
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

5.  Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas.

Authors:  S Ikematsu; A Nakagawara; Y Nakamura; S Sakuma; K Wakai; T Muramatsu; K Kadomatsu
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.